e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations
Olivier Le Rouzic, Muriel Pichavant, Emilie Frealle, Antoine Guillon, Mustapha Si-Tahar, Philippe Gosset
Source:
Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olivier Le Rouzic, Muriel Pichavant, Emilie Frealle, Antoine Guillon, Mustapha Si-Tahar, Philippe Gosset. Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations. Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Endoscopy
Related content which might interest you:
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Evidence for differential roles of Th1 and Th17 cytokines in the pathogenesis of COPD
Source: Annual Congress 2010 - Pathology and immunology of COPD
Year: 2010
IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "
in vitro
" models
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 122s
Year: 2003
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
GM-CSF is a key pathogenic mediator in experimental COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005
The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Airway inflammation in asthma: current and future targets and therapies
Source: Breathe 2010; 6: 245-252
Year: 2010
Macrolides targeting multiple immune pathways in asthma and COPD
Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Year: 2021
Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process
Source: Eur Respir J 2004; 24: Suppl. 48, 592s
Year: 2004
The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept